The 12 closest competitors and alternatives to Octant Bio among biotech companies — ranked by similarity to what Octant Bio actually does, not by market-cap band.
Subscribe to see Octant Bio’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Octant Bio is a biotechnology company that combines next-generation biology, chemistry, and computation to discover and develop precision small molecule therapeutics. The company targets complex cellular mechanisms to address genetic diseases, such as protein misfolding and mistrafficking across various therapeutic areas including genetic disorders, oncology, metabolism, and immunology.
Octant Bio is a biotech company headquartered in United States. Xcout tracks 8 named people at Octant Bio, including Mark Murcko (Leadership Team). Xcout recorded 7 job postings from Octant Bio in the last 90 days.
2 more named people on record for Octant Bio, with roles, board committees and tenure — see the full roster →
Xcout recorded 7 job postings from Octant Bio in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Octant Bio's hiring signals →
Ranked by semantic similarity — how close each company is to Octant Bio by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotech company
Sharp Therapeutics Corp. is a preclinical-stage biotechnology and drug discovery company that develops small molecule therapies to treat genetic diseases and hereditary disorders. The company combines high-speed experimentation and computational methods to advance its drug discovery platform.
Biotechnology
Matchpoint Therapeutics Inc. discovers and develops precision small molecule medicines utilizing covalent chemistry and chemoproteomics screening to treat immune diseases. The company leverages proprietary screening technologies and machine learning algorithms to expand the druggable proteome and design covalent drug candidates for patients with serious inflammatory and immune conditions.
Similar biotech company
Atavistik Bio is a U.S. biotechnology company developing small-molecule medicines by targeting allosteric sites and metabolite-regulated biology, using its chemoproteomics and drug-discovery platform. Its programs are aimed at treating cancer and other serious diseases.
Similar biotech company
Nimbus Therapeutics is a biotechnology company that uses structure-based drug discovery and computational chemistry to develop small-molecule medicines. It focuses on therapeutic areas including oncology, autoimmune disease, and metabolic disorders, serving patients through internally developed programs and pharmaceutical partnerships.
Similar biotech company
Basecamp Bio Inc. is a California-based drug discovery and development company founded in 2021. The company utilizes a structure-based drug discovery engine to develop new drugs, cell and gene therapies, regenerative medicine, and immunotherapies.
Similar biotech company
Variant Bio, Inc. is a biotechnology company that uses human genomic diversity and population genetics to discover therapeutic targets and develop medicines. It works with researchers, healthcare and biotechnology partners, and genetically diverse communities to study traits associated with health and disease.
Biotechnology
Congruence Therapeutics is a clinical-stage biotechnology company located in Montreal, Quebec, that discovers and develops small molecule correctors and allosteric modulators for protein-misfolding diseases.
Biotechnology
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Biotechnology
76Bio, Inc. is a biotechnology company founded in 2020 and based in Boston, United States. The company develops therapeutics for patients with life-threatening diseases by pioneering targeted protein degraders.
Biotechnology
Superluminal Medicines is a generative biology and chemistry company headquartered in Boston, Massachusetts, focused on drug discovery and development.
Biotechnology
Neomorph is a clinical-stage biotechnology company founded in 2020 and headquartered in San Diego, California. The company pioneers the discovery and development of molecular glue degraders to target and destroy difficult disease-causing proteins.
Biotechnology
Standard Model Biomedicine is a biotechnology research company based in San Francisco, United States. The company is focused on developing a foundation model for human biology to advance biomedical research.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Octant Bioand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →